Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach.

Madeddu C, Gramignano G, Astara G, Demontis R, Sanna E, Atzeni V, Macciò A.

Front Physiol. 2018 Sep 20;9:1294. doi: 10.3389/fphys.2018.01294. eCollection 2018. Review.

2.

The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?

Puzzoni M, Silvestris N, Leone F, Giampieri R, Faloppi L, Demurtas L, Dell'Aquila E, Marino D, Brunetti O, Garattini SK, Ongaro E, Astara G, Orgiano L, Aprile G, Santini D, Scartozzi M.

Target Oncol. 2016 Oct;11(5):593-603. Review.

PMID:
27184491
3.

The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.

Orgiano L, Pani F, Astara G, Madeddu C, Marini S, Manca A, Mantovani G.

Support Care Cancer. 2016 Oct;24(10):4293-9. doi: 10.1007/s00520-016-3262-7. Epub 2016 May 12.

PMID:
27169699
4.

Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.

Madeddu C, Mantovani G, Gramignano G, Astara G, Macciò A.

Future Oncol. 2015 Oct;11(19):2697-2710. doi: 10.2217/fon.15.195. Epub 2015 Sep 17.

PMID:
26376740
5.

Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.

Madeddu C, Dessì M, Panzone F, Serpe R, Antoni G, Cau MC, Montaldo L, Mela Q, Mura M, Astara G, Tanca FM, Macciò A, Mantovani G.

Clin Nutr. 2012 Apr;31(2):176-82. doi: 10.1016/j.clnu.2011.10.005. Epub 2011 Nov 1.

PMID:
22047681
6.

Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.

Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Massa D, Astara G, Chessa P, Mantovani G.

J Mol Med (Berl). 2010 Jul;88(7):677-86. doi: 10.1007/s00109-010-0611-8. Epub 2010 Mar 26.

PMID:
20339829
8.

Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients.

Macciò A, Madeddu C, Massa D, Astara G, Farci D, Melis GB, Mantovani G.

J Cell Mol Med. 2009 Sep;13(9B):3951-9. doi: 10.1111/j.1582-4934.2008.00408.x. Epub 2008 Jun 27.

9.

An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study.

Massa E, Madeddu C, Astara G, Pisano M, Spiga C, Tanca FM, Sanna E, Puddu I, Patteri E, Lamonica G, Deiana L, Saba F, Mantovani G.

Crit Rev Oncol Hematol. 2008 Apr;66(1):75-83. doi: 10.1016/j.critrevonc.2007.11.002. Epub 2007 Dec 27.

PMID:
18164209
10.

Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.

Riccio D, Solinas A, Astara G, Mantovani G.

Arch Gerontol Geriatr. 2007;44 Suppl 1:343-53.

PMID:
17317473
11.
12.

Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.

Gramignano G, Lusso MR, Madeddu C, Massa E, Serpe R, Deiana L, Lamonica G, Dessì M, Spiga C, Astara G, Macciò A, Mantovani G.

Nutrition. 2006 Feb;22(2):136-45.

PMID:
16459226
13.

Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.

Mantovani G, Madeddu C, Macciò A, Gramignano G, Lusso MR, Massa E, Astara G, Serpe R.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1651-9.

14.

Endoscopic laser ablation as palliative treatment of endobronchial, nonresectable, or recurrent lung cancer: assessment of its impact on quality of life.

Mantovani G, Astara G, Manca G, Versace R, Contu P, Carai A.

Clin Lung Cancer. 2000 May;1(4):277-85; discussion 286.

PMID:
14733632
15.

Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.

Mantovani G, Madeddu C, Gramignano G, Lusso MR, Mocci M, Massa E, Ferreli L, Astara G, Macciò A, Serpe R.

J Exp Ther Oncol. 2003 Jul-Aug;3(4):205-19.

PMID:
14567291
16.

Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.

Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Madeddu C, Mura L, Mudu MC, Proto E, Tore G, Mura M, Macciò A, Ferreli A, Amichetti M.

Oncol Rep. 2003 May-Jun;10(3):759-66.

PMID:
12684655
17.

Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.

Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Lusso MR, Camboni P, Ferreli L, Mocci M, Perboni S, Mura L, Madeddu C, Macciò A.

Oncol Rep. 2003 Jan-Feb;10(1):197-206.

PMID:
12469169
18.

Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.

Mantovani G, Macciò A, Madeddu C, Mulas C, Massa E, Astara G, Ferreli L, Mudu MC, Gramignano G, Murgia V, Lusso MR, Mocci M, Cardia A, Mura L.

Oncol Rep. 2002 Jul-Aug;9(4):887-96.

PMID:
12066227
19.

Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.

Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A.

Int J Oncol. 2002 Feb;20(2):419-27.

PMID:
11788911
20.

Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.

Mantovani G, Maccio A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G.

Int J Oncol. 2000 Jun;16(6):1227-33.

PMID:
10812000
21.

Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.

Mantovani G, Macciò A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G.

Oncol Rep. 1999 Nov-Dec;6(6):1425-30.

PMID:
10523724
22.

Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.

Mantovani G, Ghiani M, Curreli L, Maccio A, Massa D, Succu G, Lai P, Massa E, Mudu MC, Astara G.

Oncol Rep. 1999 Mar-Apr;6(2):421-6.

PMID:
10023014
23.

Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma.

Mantovani G, Bianchi A, Curreli L, Ghiani M, Astara G, Lampis B, Santona M, Dessi D, Esu S, Lai P, Massa E, Maccio A, Proto E.

Int J Oncol. 1997 Jan;10(1):213-21.

PMID:
21533366
24.

Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma.

Mantovani G, Gebbia V, Proto E, Cossu F, Bianchi A, Curreli L, Ghiani M, Massa E, Astara G, Lampis B, Dessi D, Santona M.

Int J Oncol. 1996 Nov;9(5):1035-43.

PMID:
21541611
25.

Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer.

Mantovani G, Gebbia V, Proto E, Cossu F, Bianchi A, Curreli L, Ghiani M, Astara G, Lampis B, Dessi D, Santona M, Massa E.

Int J Oncol. 1996 Sep;9(3):571-8.

PMID:
21541554
26.

Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial.

Mantovani G, Astara G, Lampis B, Bianchi A, Curreli L, Orrù W, Carta MG, Carpiniello B, Contu P, Rudas N.

Support Care Cancer. 1996 Mar;4(2):129-40.

PMID:
8673350
27.

Primary T cell CD30-positive anaplastic large-cell lymphoma associated with adult-onset celiac disease and presenting with skin lesions.

Mantovani G, Esu S, Astara G, Lampis B, Macciò A, Usai P, Santa Cruz G, Mura E, Ferreli A.

Acta Haematol. 1995;94(1):48-51.

PMID:
7544524
28.

Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.

Mantovani G, Macciò A, Astara G, Contini L, Esu S, Littera S, Arangino V, Lai P, Proto E, Pusceddu G, et al.

Cell Biophys. 1993 Jan-Jun;22(1-3):79-99.

PMID:
7889544
29.

Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.

Mantovani G, Astara G, Curreli L, Lai P, Turnu E, Locci F, Lantini MS, Cossu M, Riva A, Del Giacco GS.

Haematologica. 1992 Jul-Aug;77(4):326-35.

PMID:
1427443

Supplemental Content

Loading ...
Support Center